Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-19

FDA Approved: SUMATRIPTAN — Original Application (Lannett Company, Inc.)

View source ↗

Summary

The FDA approved Lannett Company's generic sumatriptan product under an original ANDA for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan (Sumatriptan)

Snippet

ORIG AP for SUMATRIPTAN (SUMATRIPTAN)